Provenienza dei contatti di primo grado di Michael G. Dunn
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
NovoPedics, Inc.
NovoPedics, Inc. Medical SpecialtiesHealth Technology NovoPedics, Inc. develops implantable medical devices that restore mobility to patients suffering from severe meniscus knee injuries. It provides a way to replace damaged meniscus tissue with a patented fiber-reinforced design similar to the native meniscus and can be attached to both soft tissue and bone, allowing it to be used in total meniscus replacement surgery. The company was founded by Charles J. Gatt Jr. and Michael G. Dunn in 2013 and is headquartered in New Brunswick, NJ.
3
| Holding Company | Medical Specialties | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Michael G. Dunn tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Biotechnology | Corporate Officer/Principal | |
KPMG, Inc.
KPMG, Inc. Miscellaneous Commercial ServicesCommercial Services Part of KPMG International Cooperative, KPMG, Inc. provides audit and accounting services. The company is based in Vancouver, Canada. The CEO of the Canadian company is Walter R. Pela. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Medicine & Dentistry of New Jersey | College/University | Corporate Officer/Principal | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
Franklin Pierce College | College/University | Graduate Degree | |
Rider University | College/University | Undergraduate Degree | |
State University of St. Petersburg | College/University | Corporate Officer/Principal | |
Learning Ally, Inc.
Learning Ally, Inc. Miscellaneous Commercial ServicesCommercial Services Learning Ally, Inc. provides educational support services. It produces & distributes tapes and CD-ROMs of textbooks for students as well as recordings of reference and professional materials to individuals with print disabilities such as blindness, visual impairments and dyslexia. The company was founded by Anne T. MacDonald in 1948 and is headquartered in Princeton, NJ. | Miscellaneous Commercial Services | Treasurer | |
Foundation Venture Capital Group LLC
Foundation Venture Capital Group LLC Investment ManagersFinance Foundation Venture Capital Group LLC (Foundation Venture) is a venture capital firm headquartered in Princeton, New Jersey. Founded in 2006, the firm is the equity investment arm of New Jersey Health Foundation Inc. | Investment Managers | President | |
New Jersey Health Foundation, Inc. | Financial Conglomerates | President | |
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Celvive, Inc.
Celvive, Inc. Miscellaneous Commercial ServicesCommercial Services Celvive, Inc. engages in the development of technology for the isolation and use of autologous cellular therapy for regenerative medicine applications. It specializes in using a closed bag system to isolate specific adult stem cells from the patients' own bone marrow. The company was founded by Hatem E. Sabaawy in 2011 and is headquartered in New Brunswick, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
Nemagen Discoveries, Inc.
Nemagen Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services NemaGen Discoveries, Inc. is a biotech company located in Princeton, NJ. The company focuses on developing therapies for patients with allergic inflammation and mast cell-related diseases. NemaGen's unique approach to drug development involves investigating the body's natural ability to prevent unwanted inflammation following parasitic infections. Recently, NemaGen announced its participation in the NIH I-Corps program to better understand stakeholders' needs and validate the value of its therapies. The company was founded by Mark Siracusa and has been led by CEO Nicholas Shubin since 2022. | Miscellaneous Commercial Services | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 15 |
Canada | 2 |
Francia | 2 |
Russia | 2 |
Settori
Consumer Services | 6 |
Health Technology | 5 |
Commercial Services | 5 |
Finance | 4 |
Health Services | 2 |
Posizioni
Director/Board Member | 10 |
Corporate Officer/Principal | 5 |
President | 3 |
Undergraduate Degree | 2 |
Treasurer | 1 |
Contatti più connessi
Insiders | |
---|---|
James Golubieski | 13 |
Vincent Smeraglia | 6 |
Charles J. Gatt | 1 |
- Borsa valori
- Insiders
- Michael G. Dunn
- Connessioni Società